This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
CAR-T “the living drugs”, immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy
Journal of Hematology & Oncology Open Access 08 November 2019
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wu, C. et al. Olfactory receptor 544 reduces adiposity by steering fuel preference toward fats. J. Clin. Invest. 127, 4118–4123 (2017)10.1172/JCI89344
Rights and permissions
About this article
Cite this article
Crunkhorn, S. Ectopic olfactory receptor activation reverses obesity. Nat Rev Drug Discov 16, 826–827 (2017). https://doi.org/10.1038/nrd.2017.230
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2017.230
This article is cited by
-
CAR-T “the living drugs”, immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy
Journal of Hematology & Oncology (2019)